Handbook home
Introduction to Biomedical Enterprise (HLTH90021)
Graduate courseworkPoints: 12.5On Campus (Parkville)
About this subject
- Overview
- Eligibility and requirements
- Assessment
- Dates and times
- Further information
- Timetable(opens in new window)
Contact information
Semester 2
James Ziogas
Overview
Availability | Semester 2 |
---|---|
Fees | Look up fees |
This subject will offer students a foundation in the principles involved in developing a biomedical research discovery into a new therapeutic approach. In a series of 10x 3 hour workshops students will be introduced to the basics of research translation and the importance of data management and intellectual property strategy. Students will learn about the process and time scales involved in technology transfer and the challenges of transitioning from a research mindset into a development mindset. They will learn about the regulatory framework required to progress biomedical discoveries and the importance of project management, negotiation and relationship building with industry and government. Each module consists of a masterclass presented by area experts, supported by webinars and print resources to deepen further the understanding of the topic.
Intended learning outcomes
Apply innovative thinking in relation to the commercial and legal challenges of translating basic research
Generic skills
- Demonstrate advanced independent critical enquiry, analysis and reflection
- Be able to synthesise and evaluate knowledge across a range of disciplines
- Reach a high level of achievement in writing, research or project activities, problem-solving and communication
- Be critical and creative thinkers, with an aptitude for continued self-directed learning
- Have a set of flexible and transferable skills for different types of employment
- Be able to initiate and implement constructive change in their communities, including professions and workplaces
Last updated: 3 November 2022
Eligibility and requirements
Prerequisites
None
Corequisites
None
Non-allowed subjects
None
Inherent requirements (core participation requirements)
The University of Melbourne is committed to providing students with reasonable adjustments to assessment and participation under the Disability Standards for Education (2005), and the Assessment and Results Policy (MPF1326). Students are expected to meet the core participation requirements for their course. These can be viewed under Entry and Participation Requirements for the course outlines in the Handbook.
Further details on how to seek academic adjustments can be found on the Student Equity and Disability Support website: http://services.unimelb.edu.au/student-equity/home
Last updated: 3 November 2022
Assessment
Description | Timing | Percentage |
---|---|---|
Two individual case studies of biomedical discoveries that have dealt with the challenges of moving from the bench to the bedside. (750 words each) (approx weeks 4-5 & weeks 8-10)
| During the teaching period | 30% |
Develop a strategy for translating a new biomedical discovery into an approved therapeutic use.
| During the examination period | 50% |
Participation based on attendance and contribution to class discussions and case presentations. Students will be required to participate in LMS/PIAZZA discussion and post summaries that will form part of the assessment. | Throughout the semester | 20% |
Last updated: 3 November 2022
Dates & times
- Semester 2
Principal coordinator James Ziogas Mode of delivery On Campus (Parkville) Contact hours 30 Total time commitment 170 hours Teaching period 29 July 2019 to 27 October 2019 Last self-enrol date 9 August 2019 Census date 31 August 2019 Last date to withdraw without fail 27 September 2019 Assessment period ends 22 November 2019 Semester 2 contact information
James Ziogas
Last updated: 3 November 2022
Further information
- Texts
Prescribed texts
There are no specifically prescribed or recommended texts for this subject.
Last updated: 3 November 2022